Kojin Therapeutics

📍 Boston, United States🗓 Founded 2020👥 11 employees💰 Last funded Oct 2023
Biotechnology Research🌐 kojintx.com
Website LinkedIn
Based in Boston, Massachusetts and named after the Japanese deity that tamed fire for the good of humanity, Kojin is harnessing groundbreaking discoveries in cell-state and ferroptosis biology to develop first-in-class treatments for use in patients with cancer, and autoimmune and inflammatory diseases, among other disorders. Kojin has developed a drug-discovery platform that integrates computational chemistry, structural biology, chemical biology, target-informed screening, and mechanism-driven pharmacology to discover therapeutics that specifically modulate ferroptosis, a recently discovered and characterized cell-death mechanism. The Kojin team brings together scientific leadership in chemical biology, genetics, immunology, cancer therapeutics, drug discovery, and clinical development, as well as broad experience in biotechnology entrepreneurship.
6
Total investors
5
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United States
4
United Kingdom
1
Switzerland
1
Investor activity2020–2023 · investors recorded per year
202012021420231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Kojin Therapeutics?
Kojin Therapeutics has 6 investors on record on gritt.io, including 5 early-stage backers, 1 mid-stage.
When did Kojin Therapeutics last raise funding?
The most recent investment in Kojin Therapeutics recorded on gritt.io was in October 2023.
When was Kojin Therapeutics founded?
Kojin Therapeutics was founded in 2020.
What industry is Kojin Therapeutics in?
Kojin Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Kojin Therapeutics based?
Kojin Therapeutics is headquartered in Boston, United States.